drugset / Trial / NCT01338805
Phase II BGG492 Capsule Extension for Partial Epilepsy
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This long-term extension study will assess the safety, tolerability and efficacy of BGG492 as adjunctive treatment in patients with partial onset seizures.
Timeline
- Start
- 2011-06
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | selurampanel | Small molecule | 50 mg | Oral |
| Subject | selurampanel | Small molecule | 100 mg | Oral |
| Subject | selurampanel | Small molecule | 150 mg | Oral |